Inhoud
Menu
Hoofdmenu
Home
Actueel
Onderwerpen
Subsidies & Financiering
Over ons
Service menu right
english.rvo.nl
Direct regelen
Home
Development of a balanced dual PI3K/mTOR kinase inhibitor: A new generation of potential drugs for targeted cancer therapy
Terug naar details